EZH2 mutational status predicts poor survival in myelofibrosis.

Abstract:

:We genotyped 370 subjects with primary myelofibrosis (PMF) and 148 with postpolycythemia vera/postessential thrombocythemia (PPV/PET) MF for mutations of EZH2. Mutational status at diagnosis was correlated with hematologic parameters, clinical manifestations, and outcome. A total of 25 different EZH2 mutations were detected in 5.9% of PMF, 1.2% of PPV-MF, and 9.4% of PET-MF patients; most were exonic heterozygous missense changes. EZH2 mutation coexisted with JAK2V617F or ASXL1 mutation in 12 of 29 (41.4%) and 6 of 27 (22.2%) evaluated patients; TET2 and CBL mutations were found in 2 and 1 patients, respectively. EZH2-mutated PMF patients had significantly higher leukocyte counts, blast-cell counts, and larger spleens at diagnosis, and most of them (52.6%) were in the high-risk International Prognostic Score System (IPSS) category. After a median follow-up of 39 months, 128 patients (25.9%) died, 81 (63.3%) because of leukemia. Leukemia-free survival (LFS) and overall survival (OS) were significantly reduced in EZH2-mutated PMF patients (P = .028 and P < .001, respectively); no such impact was seen for PPV/PET-MF patients, possibly due to the low number of mutated cases. In multivariate analysis, survival of PMF patients was predicted by IPSS high-risk category, a < 25% JAK2V617F allele burden, and EZH2 mutation status. We conclude that EZH2 mutations are independently associated with shorter survival in patients with PMF.

journal_name

Blood

journal_title

Blood

authors

Guglielmelli P,Biamonte F,Score J,Hidalgo-Curtis C,Cervantes F,Maffioli M,Fanelli T,Ernst T,Winkelman N,Jones AV,Zoi K,Reiter A,Duncombe A,Villani L,Bosi A,Barosi G,Cross NC,Vannucchi AM

doi

10.1182/blood-2011-06-363424

subject

Has Abstract

pub_date

2011-11-10 00:00:00

pages

5227-34

issue

19

eissn

0006-4971

issn

1528-0020

pii

blood-2011-06-363424

journal_volume

118

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.

    abstract::One of the most serious complications of successful treatments for Hodgkin's disease is an increased incidence of acute nonlymphocytic leukemia (ANLL) and other malignancies. A retrospective analysis carried out on 1032 consecutive patients with Hodgkin's disease admitted to our Institute between 1965 and 1978 and tre...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Valagussa P,Santoro A,Fossati Bellani F,Franchi F,Banfi A,Bonadonna G

    更新日期:1982-03-01 00:00:00

  • p53 at the crossroads of MPN treatment.

    abstract::In this issue of Blood, Lu et al describe the cooperation between an orally bioavailable mouse double minute 2 (MDM2) antagonist (RG7112) and the pegylated interferon α (Peg-IFNα 2a) to target JAK2V617F hematopoietic progenitors and stem cells. Their work provides a rationale for the treatment of patients suffering fr...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2014-06-579623

    authors: Plo I

    更新日期:2014-07-31 00:00:00

  • cAMP-induced secretion of endothelial von Willebrand factor is regulated by a phosphorylation/dephosphorylation switch in annexin A2.

    abstract::The large multimeric glyocoprotein von Willebrand factor (VWF) is a crucial component of both primary and secondary hemostasis. It is stored in secretory granules of vascular endothelial cells, the Weibel-Palade bodies (WPBs), and is released following stimulation by agonists that raise intracellular Ca(2+) or cyclic ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-12-475251

    authors: Brandherm I,Disse J,Zeuschner D,Gerke V

    更新日期:2013-08-08 00:00:00

  • The missense mutation Arg593 --> Cys is related to antibody formation in a patient with mild hemophilia A.

    abstract::The development of inhibitory antibodies to factor VIII in patients affected by a mild form of hemophilia A (factor VIII > 0.05 IU/mL) is considered a rare event. In this study, we evaluated the relationship between genotype and anti-factor VIII antibody formation in a patient with mild hemophilia A. Mutation analysis...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fijnvandraat K,Turenhout EA,van den Brink EN,ten Cate JW,van Mourik JA,Peters M,Voorberg J

    更新日期:1997-06-15 00:00:00

  • Interleukin-1, tumor necrosis factor, and the production of colony-stimulating factors by cultured mesenchymal cells.

    abstract::Although the genes for four hematopoietic colony-stimulating factors (CSFs) have been cloned, neither the mechanism of the regulation of their production nor their cellular origins have been established with certainty. Monocytes are known to produce colony-stimulating and burst-promoting activities, as well as several...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sieff CA,Niemeyer CM,Mentzer SJ,Faller DV

    更新日期:1988-10-01 00:00:00

  • Lectin-like cell adhesion molecule 1 mediates leukocyte rolling in mesenteric venules in vivo.

    abstract::During the inflammatory response, granulocytes and other leukocytes adhere to and emigrate from small venules. Before firm attachment, leukocytes are observed rolling slowly along the endothelium in venules of most tissues accessible to intravital microscopy. The molecular mechanism underlying this early type of leuko...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ley K,Gaehtgens P,Fennie C,Singer MS,Lasky LA,Rosen SD

    更新日期:1991-06-15 00:00:00

  • Lymphoma regression induced by monoclonal anti-idiotypic antibodies correlates with their ability to induce Ig signal transduction and is not prevented by tumor expression of high levels of bcl-2 protein.

    abstract::Custom-made monoclonal anti-idiotype antibodies (anti-Id MoAbs) have been tested as a treatment modality in 34 non-Hodgkin's lymphoma (NHL) patients. Partial or complete tumor remissions have been induced with this treatment in 68% of these patients. One mechanism by which anti-idiotype antibodies may have induced the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Vuist WM,Levy R,Maloney DG

    更新日期:1994-02-15 00:00:00

  • Can Treg elimination enhance NK cell therapy for AML?

    abstract::In this issue of Blood, Bachanova et al describe how modulation of the inhibitory tumor environment may enhance natural killer (NK) cell clinical activity and produce encouraging results in the treatment of refractory acute myeloid leukemia (AML). NK cells are highly proliferative, early responders of the innate immun...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2014-05-570291

    authors: Rooney CM

    更新日期:2014-06-19 00:00:00

  • Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma.

    abstract::Enhanced tolerance to combination chemotherapy has been cited as an ancillary benefit of staging laparotomy and splenectomy in Hodgkin's disease. Seventeen patients with Hodgkin's disease and 15 with non-Hodgkin's lymphoma were subjected to nontherapeutic splenectomy as part of the staging procedure prior to their ini...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ihde DC,DeVita VT,Canellos GP,Young RC

    更新日期:1976-02-01 00:00:00

  • Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.

    abstract::Hemophilic bleeding into joints causes synovial and microvascular proliferation and inflammation (hemophilic synovitis) that contribute to end-stage joint degeneration (hemophilic arthropathy), the major morbidity of hemophilia. New therapies are needed for joint deterioration that progresses despite standard intraven...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-01-131417

    authors: Sun J,Hakobyan N,Valentino LA,Feldman BL,Samulski RJ,Monahan PE

    更新日期:2008-12-01 00:00:00

  • Regulation of acute graft-versus-host disease by microRNA-155.

    abstract::Acute graft-versus-host disease (aGVHD) remains a major complication of allogeneic hematopoietic stem cell transplant (alloHSCT), underscoring the need to further elucidate its mechanisms and develop novel treatments. Based on recent observations that microRNA-155 (miR-155) is up-regulated during T-cell activation, we...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-387522

    authors: Ranganathan P,Heaphy CE,Costinean S,Stauffer N,Na C,Hamadani M,Santhanam R,Mao C,Taylor PA,Sandhu S,He G,Shana'ah A,Nuovo GJ,Lagana A,Cascione L,Obad S,Broom O,Kauppinen S,Byrd JC,Caligiuri M,Perrotti D,Hadley G

    更新日期:2012-05-17 00:00:00

  • Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia.

    abstract::Val34Leu polymorphism of the A subunit of coagulation factor XIII (FXIII-A) is located in the activation peptide (AP) just 3 amino acids away from the thrombin cleavage site. This mutation has been associated with a protective effect against occlusive arterial diseases and venous thrombosis; however, its biochemical c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Balogh I,Szôke G,Kárpáti L,Wartiovaara U,Katona E,Komáromi I,Haramura G,Pfliegler G,Mikkola H,Muszbek L

    更新日期:2000-10-01 00:00:00

  • The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy.

    abstract::A deficiency of adenosine deaminase, an enzyme important in purine nucleoside catabolism, is associated with a severe combined immunodeficiency disease in children. Inhibition of this enzyme in vitro and in vivo results in an impairment in lymphoblast proliferation. We have investigated the pharmacologic inhibition of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Grever MR,Siaw MF,Jacob WF,Neidhart JA,Miser JS,Coleman MS,Hutton JJ,Balcerzak SP

    更新日期:1981-03-01 00:00:00

  • Immunocytochemical study of the binding of fibrinogen and thrombospondin to ADP- and thrombin-stimulated human platelets.

    abstract::We have used immunogold staining to locate thrombospondin (TSP) on thrombin-activated human platelets, and have compared its distribution with that of fibrinogen (or fibrin) on thrombin- and ADP-stimulated platelets. To do this, isolated platelets were incubated with monospecific antibodies to TSP or fibrinogen (fib) ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hourdillé P,Hasitz M,Belloc F,Nurden AT

    更新日期:1985-04-01 00:00:00

  • Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis.

    abstract::Mpl ligand (thrombopoietin [TPO]) is the physiological regulator of platelet production. In mice, mRNA encoding the Mpl ligand (Mpl-L) is predominantly found by Northern blot analysis in the liver and kidney. To investigate the mode of regulation of the Mpl-L gene, we have developed several experimental models of seve...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cohen-Solal K,Villeval JL,Titeux M,Lok S,Vainchenker W,Wendling F

    更新日期:1996-10-01 00:00:00

  • SUMOylation-disrupting WAS mutation converts WASp from a transcriptional activator to a repressor of NF-κB response genes in T cells.

    abstract::In Wiskott-Aldrich syndrome (WAS), immunodeficiency and autoimmunity often comanifest, yet how WAS mutations misregulate chromatin-signaling in Thelper (TH) cells favoring development of auto-inflammation over protective immunity is unclear. Previously, we identified an essential promoter-specific, coactivator role of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-05-646182

    authors: Sarkar K,Sadhukhan S,Han SS,Vyas YM

    更新日期:2015-10-01 00:00:00

  • Longitudinal analysis of point mutations of the N-ras proto-oncogene in patients with myelodysplasia using archived blood smears.

    abstract::We performed a longitudinal analysis of point mutations of the N-ras proto-oncogene in patients with myelodysplasia and a follow-up of at least 2.5 years after diagnosis. Point mutations at codons 12, 13, and 61 of the N-ras oncogene were analyzed after in vitro amplification of N-ras specific sequences followed by do...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: van Kamp H,de Pijper C,Verlaan-de Vries M,Bos JL,Leeksma CH,Kerkhofs H,Willemze R,Fibbe WE,Landegent JE

    更新日期:1992-03-01 00:00:00

  • Monoclonal antibody to the interferon-inducible protein Leu-13 triggers aggregation and inhibits proliferation of leukemic B cells.

    abstract::Interferon (IFN)-alpha inhibits DNA synthesis stimulated by low molecular weight B-cell growth factor (BCGF) in hairy cells in vitro, suggesting that the therapeutic efficacy of IFN-alpha in hairy cell leukemia (HCL) involves growth inhibition of malignant B cells. Evidence that the 16-Kd cell surface protein Leu-13 m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Evans SS,Lee DB,Han T,Tomasi TB,Evans RL

    更新日期:1990-12-15 00:00:00

  • Gene therapy, an ongoing revolution.

    abstract::In this issue of Blood, Buchlis and colleagues describe the long-term persistence (up to 10 years) of factor IX (FIX) expression in adeno-associated virus serotype 2 (AAV-2)–injected muscles of a patient with hemophilia B. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-02-409086

    authors: Benveniste O

    更新日期:2012-03-29 00:00:00

  • Platelet storage at 22 degrees C: role of gas transport across plastic containers in maintenance of viability.

    abstract::Containers constructed of polyvinylchloride (PVC) are used for the storage of platelet concentrates (PC) for transfusion, At 22 degrees C, pH often falls to such low levels (pH is less that 6.0) that viability is lost. Far lesser degrees of pH fall are observed in bags constructed of polyethylene (PE). In this study, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Murphy S,Gardner FH

    更新日期:1975-08-01 00:00:00

  • The multifaceted role of fibrinogen in tissue injury and inflammation.

    abstract::The canonical role of the hemostatic and fibrinolytic systems is to maintain vascular integrity. Perturbations in either system can prompt primary pathological end points of hemorrhage or thrombosis with vessel occlusion. However, fibrin(ogen) and proteases controlling its deposition and clearance, including (pro)thro...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2018-07-818211

    authors: Luyendyk JP,Schoenecker JG,Flick MJ

    更新日期:2019-02-07 00:00:00

  • Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation.

    abstract::Tumor necrosis factor (TNF)-related activation-induced cytokine (TRANCE) induces osteoclast formation from monocyte/macrophage lineage cells via various transcription factors, including the Mi transcription factor (Mitf). Here, we show that inhibitors of differentiation/DNA binding (Ids), helix-loop-helix (HLH) transc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-07-2798

    authors: Lee J,Kim K,Kim JH,Jin HM,Choi HK,Lee SH,Kook H,Kim KK,Yokota Y,Lee SY,Choi Y,Kim N

    更新日期:2006-04-01 00:00:00

  • Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion.

    abstract::The present studies were undertaken to determine whether factor VIII/von Willebrand factor (vWF) present in the vessel wall (in addition to that in plasma) may mediate the attachment of platelets to subendothelium. Subendothelium from everted rabbit aorta was exposed to human citrated blood flowing through an annular ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Turitto VT,Weiss HJ,Zimmerman TS,Sussman II

    更新日期:1985-04-01 00:00:00

  • Hematopoiesis on cellulose ester membranes. XI. Induction of new bone and a hematopoietic microenvironment by matrix factors secreted by marrow stromal cells.

    abstract::Cellulose ester membranes (CEM) were coated with stromal cells from bone marrow (BM) or bone and implanted intraperitoneally (IP) in CAF1 mice for intervals of 1 to 6 months. Previous studies indicated that matrix factors [glycoproteins (GPs), proteoglycans (PGs), and glycosaminoglycans (GAGs)] were secreted by the re...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Knospe WH,Husseini SG,Fried W

    更新日期:1989-07-01 00:00:00

  • Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.

    abstract::Langerhans cell histiocytosis (LCH) and Erdheim-Chester disease (ECD) are rare histiocytic disorders induced by somatic mutation of MAPK pathway genes. BRAFV600E mutation is the most common mutation in both conditions and also occurs in the hematopoietic neoplasm hairy cell leukemia (HCL). It is not known if adult LCH...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-12-757823

    authors: Milne P,Bigley V,Bacon CM,Néel A,McGovern N,Bomken S,Haniffa M,Diamond EL,Durham BH,Visser J,Hunt D,Gunawardena H,Macheta M,McClain KL,Allen C,Abdel-Wahab O,Collin M

    更新日期:2017-07-13 00:00:00

  • Discontinuation of fucose therapy in LADII causes rapid loss of selectin ligands and rise of leukocyte counts.

    abstract::Leukocyte adhesion deficiency type II (LADII) is a rare inherited disorder of fucose metabolism. Patients with LADII lack fucosylated glycoconjugates, including the carbohydrate ligands of the selectins, leading to an immunodeficiency caused by the lack of selectin-mediated leukocyte-endothelial interactions. A simple...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.1.330

    authors: Lühn K,Marquardt T,Harms E,Vestweber D

    更新日期:2001-01-01 00:00:00

  • Functional imaging of shear-dependent activity of ADAMTS13 in regulating mural thrombus growth under whole blood flow conditions.

    abstract::The metalloprotease ADAMTS13 is assumed to regulate the functional levels of von Willebrand factor (VWF) appropriate for normal hemostasis in vivo by reducing VWF multimer size, which directly represents the thrombogenic activity of this factor. Using an in vitro perfusion chamber system, we studied the mechanisms of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-110700

    authors: Shida Y,Nishio K,Sugimoto M,Mizuno T,Hamada M,Kato S,Matsumoto M,Okuchi K,Fujimura Y,Yoshioka A

    更新日期:2008-02-01 00:00:00

  • Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in Folliculin Interacting Protein 1 deficiency.

    abstract::Agammaglobulinemia is the most profound primary antibody deficiency that can occur due to an early termination of B-cell development. We here investigated 3 novel patients, including the first known adult, from unrelated families with agammaglobulinemia, recurrent infections, and hypertrophic cardiomyopathy (HCM). Two...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020006441

    authors: Saettini F,Poli C,Vengoechea J,Bonanomi S,Orellana JC,Fazio G,Rodriguez FH,Noguera LP,Booth CA,Jarur-Chamy V,Shams M,Iascone M,Vukic M,Gasperini S,Quadri M,Barroeta Seijas AB,Rivers E,Mauri M,Badolato R,Cazzaniga G

    更新日期:2020-09-09 00:00:00

  • Variable region gene analysis of an isotype-switched (IgA) variant of chronic lymphocytic leukemia.

    abstract::Chronic lymphocytic leukemia of B-cell origin (B-CLL) is generally thought to arise by neoplastic transformation of B lymphocytes, which express CD5 and have features of an early stage of B-cell differentiation. To study isotype-switched B-CLL as a potentially more differentiated variant, we performed genetic and func...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Friedman DF,Moore JS,Erikson J,Manz J,Goldman J,Nowell PC,Silberstein LE

    更新日期:1992-11-01 00:00:00

  • 2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells.

    abstract::We report an RNA targeting strategy, which selectively degrades bcr/abl mRNA in chronic myelogenous leukemia (CML) cells. A 2', 5'-tetraadenylate activator (2-5A) of RNase L was chemically linked to oligonucleotide antisense directed against either the fusion site or against the translation start sequence in bcr/abl m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Maran A,Waller CF,Paranjape JM,Li G,Xiao W,Zhang K,Kalaycio ME,Maitra RK,Lichtin AE,Brugger W,Torrence PF,Silverman RH

    更新日期:1998-12-01 00:00:00